WITHDRAWN: Systemic treatments for metastatic cutaneous melanoma.

CONCLUSIONS: There is no evidence from randomised controlled clinical trials to show superiority of systemic therapy over best supportive care / placebo in the treatment of malignant cutaneous melanoma.Given that patients with metastatic melanoma frequently receive systemic therapy, it is our pragmatic view that a future systematic review could compare any systemic treatment, or combination of treatments, to single agent dacarbazine. PMID: 29411867 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29411867?dopt=Abstract

Source: Cochrane Database of Systematic Reviews - February 7, 2018 Category: General Medicine Authors: Crosby T, Fish R, Coles B, Mason M Tags: Cochrane Database Syst Rev Source Type: research